Kerala will soon start a clinical trial of blood plasma therapy for the treatment of corona virus. This will be the first state in the country to do so. In Blood Plazma Therapy, the blood of a recuperated patient is used in another patient.
The Indian Council of Medical Research has approved a clinical trial of blood plasma therapy for the treatment of corona virus. Kerala will be the first state to use this therapy on Kovid-19 patients. He sought permission for this. The ICMR is in the final stages of creating a protocol for the clinical trial of this therapy.
What is blood plasma therapy?
This therapy uses the blood of those who have recovered after treatment. South Korea has been successful in therapy. It has been tried on two people there, which are getting good results. During the trial in Korea, taking antibodies from the blood of patients who had been cured of the corona, they were used to treat critically ill Kovid-19 patients.
According to this therapy, antibodies in the blood plasma of a cured patient are helpful in increasing immunity in the blood of another patient. It is more than 100 years old therapy. This method was used in the 1918 flu, smallpox, pneumonia, and many other infections.
Kerala will do a clinical trial
The clinical trial of blood plasma therapy was initiated by the prestigious Sri Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) in Kerala. Even after getting the green signal from ICMR, Kerala will have to get approval from the Drug Controller General of India (DCGI) for the clinical trial of this therapy. It is clear from the name of the clinical trial that it will be for testing, so it will be used only on patients who are seriously ill or on the ventilator. If the results are good, then the process of sanctioning it for the treatment of patients will start.